UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
Derma Sciences, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, $0.01 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
249827205
--------------------------------------------------------------------------------
(CUSIP Number)
Raymond C. Hedger
Hedger & Hedger
1800 Linglestown Road, Suite 206, Harrisburg, PA 17110
(717)238-1800
--------------------------------------------------------------------------------
Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
September 1, 2000
--------------------------------------------------------------------------------
(Date of Event which Requires Filing
of this Statement)
If the filing person has previously filed a statement of Schedule 13G to report
the acquisition which is the subject of the Schedule 13D, and is filing this
schedule because of ss. 240.13d-1(e), ss. 240.13d-1(f) or ss. 240.13d-1(g),
check the following box [ ].
Note: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See ss. 240.13d-7(b) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
(Continued on following page(s))
<PAGE>
Schedule 13D
CUSIP No. 249827205 Page 2 of 5 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Mary G. Clark, RN ###-##-####
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
Not applicable (additional consideration not required)
--------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS 2(d) OR 2(e) [ ]
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF SHARES 7 SOLE VOTING POWER
BENEFICALLY 185,095
-----------------------------------------------------
OWNED BY EACH 8 SHARED VOTING POWER
REPORTING
-----------------------------------------------------
PERSON WITH 9 SOLE DISPOSITIVE POWER
185,095
-----------------------------------------------------
10 SHARED DISPOSITIVE POWER
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
185,095
--------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
[ ]
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
8.8%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT!
<PAGE>
Schedule 13D
CUSIP No. 249827205 Page 3 of 5 Pages
ITEM 1. SECURITY AND ISSUER
This Schedule 13D relates to the common stock, $.01 par value (the "Common
Stock"), of Derma Sciences, Inc., a Pennsylvania corporation (the "Issuer"),
whose principal executive offices are located at 214 Carnegie Center, Suite 100,
Princeton, New Jersey 08540.
ITEM 2. IDENTITY AND BACKGROUND
This Schedule 13D is being filed by Mary G. Clark, RN (the "Reporting Person").
Certain information with respect to the Reporting Person is set forth below:
Name and Address: Mary G. Clark, RN
201 Joleona Drive
Clarks Summit, PA 18411
Principal Occupation: Special Consultant for Scientific
Affairs to the Issuer; founder
and director of the Issuer
Criminal convictions: None
Civil proceedings: None
Citizenship: United States
<PAGE>
Schedule 13D
CUSIP No. 249827205 Page 4 of 5 Pages
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
The issuance to the Reporting Person of the Issuer's securities as described
under Item 5 did not involve the payment by the Reporting Person of cash or
other consideration.
ITEM 4. PURPOSES OF THE TRANSACTIONS
The purpose of the reported acquisition of options to purchase the Issuer's
Common Stock is investment without a view, presently or ultimately, to acquiring
control of the Issuer. The Reporting Person serves as a member of the board of
directors of the Issuer. In this capacity, the Reporting Person has proposed,
and may in the future propose, candidates for election to the Issuer's board of
directors. There is no agreement or arrangement between the Reporting Person and
the Issuer with respect to election of candidates proposed by the Reporting
Person. The inclusion of such candidates in management's slate of directors to
be submitted for consideration by the Issuer's shareholders is entirely at the
discretion of the Issuer's board of directors.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
The following table sets forth shares of the Issuer's Common Stock as to which
the Reporting Person maintains beneficial ownership. The Reporting Person
maintains both voting power and dispositive power relative to all such shares:
Beneficial Common Stock Ownership
Owned outright 155,095
Exercisable options (1) 30,000
-------
Total beneficially owned 185,095
=======
Percentage of class beneficially owned 8.8%
------------------
(1) Exercisable at $0.75 per share.
On August 1, 2000 the Reporting Person was awarded options to purchase 15,000
share of Common Stock pursuant to the Issuer's Outside Directors' Stock Option
Plan. The options are fully vested, are exercisable at $0.75 per share and
expire on August 1, 2010.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER
None.
<PAGE>
Schedule 13D
CUSIP No. 249827205 Page 5 of 5 Pages
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
None.
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
/s/ Mary G. Clark
-------------------------------------------
By: Raymond C. Hedger, Jr.
Attorney-in-Fact
September 11, 2000
ATTACHMENT:
LIMITED POWER OF ATTORNEY
I, THE UNDERSIGNED MARY G. CLARK, hereby authorize and appoint Raymond C.
Hedger, Jr., Hedger & Hedger, Harrisburg, Pennsylvania, as my attorney-in-fact
for me and on my behalf to file such Schedules 13D, and amendments thereto,
with the United States Securities and Exchange Commission and National
Securities Exchanges as may be required under the Securities Exchange Act of
1934, Regulations thereunder and the Rules of said Exchanges.
IN WITNESS WHEREOF, I have hereunder placed my hand this 23rd day of
January, 1998.
/s/ Mary G. Clark
-------------------------
Mary G. Clark
